Please use this identifier to cite or link to this item:
Title: The fentanyls: pharmacological and clinical aspects relevant to Australia.
Austin Authors: Greene, Shaun L ;Scamvougeras, Anton;Norman, Amanda;Bonomo, Yvonne;Castle, David J
Affiliation: Austin Health, Heidelberg, Victoria, Australia
University of British Columbia, Canada
St Vincent's Hospital Melbourne, Australia
The University of Melbourne, Australia
St Vincent's Hospital, Australia
Issue Date: 11-May-2020 2020-05-11
Publication information: Australasian Psychiatry 2020; 28(5): 542-544
Abstract: North American and other jurisdictions have seen an alarming rise in the abuse of the fentanyls, with related overdose deaths. We sought to review this group of drugs to alert Australian psychiatrists and drug and alcohol clinicians to their clinical effects and potential harms. The extreme potency of the fentanyls underlie their lethality. Vigilance and investment from both policy makers and health care providers are required to mitigate harm from a possible future Australian fentanyl epidemic.
DOI: 10.1177/1039856220917317
ORCID: 0000-0002-3075-1580
Journal: Australasian Psychiatry
PubMed URL: 32392080
Type: Journal Article
Subjects: addiction
drug policy
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Jan 27, 2023

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.